U.S. Home Infusion Therapy Market registering a CAGR of 7.5% during the forecast period 2022 to 2030
U.S. Home Infusion Therapy Industry Overview The U.S. home infusion therapy market size was estimated at USD 16.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. The growing elderly population prone to various severe disorders is one of the major drivers for the market growth. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth. The COVID-19 outbreak increased the importance and demand for medical devices especially in a home-based setting as the virus is transmitted through physical contact. The market witnessed revenue growth in 2020, but the key players faced supply chain bottlenecks. However, in 2021, key players like Baxter, Option Healthcare, and Smiths Medical reported a soaring revenue increase as compared to 2020, especially in the U.S. ...